Noah D Kauff

Noah D Kauff

UNVERIFIED PROFILE

Are you Noah D Kauff?   Register this Author

Register author
Noah D Kauff

Noah D Kauff

Publications by authors named "Noah D Kauff"

Are you Noah D Kauff?   Register this Author

59Publications

1103Reads

46Profile Views

High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

Radiology 2017 11 16;285(2):472-481. Epub 2017 Jun 16.

From the Department of Radiology (S.N., Y.L., M.M., M.D., S.A.J., K.J., R.E.S., H.A.V., H.H., E.S.), Department of Epidemiology and Biostatistics (M.G., D.A.G.), Clinical Genetics Service, Department of Medicine (A.G.A., N.D.K.), and Department of Pathology (R.A.S.), Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017161697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673044PMC
November 2017

Is There a Role for Ovarian Cancer Screening in High-Risk Women?

J Clin Oncol 2017 05 6;35(13):1384-1386. Epub 2017 Mar 6.

Andrew Berchuck, Laura J. Havrilesky, and Noah D. Kauff, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0045DOI Listing
May 2017

Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations-Reply.

JAMA Oncol 2017 03;3(3):417-418

Clinical Cancer Genetics Program, Duke Cancer Institute, Duke University Health System, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3900DOI Listing
March 2017

Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.

Am J Surg Pathol 2016 Mar;40(3):404-9

*Department of Pathology †Department of Surgery, Division of Gynecology ‡Deparment of Medicine, Clinical Genetics Service ∥Department of Radiology, Memorial Sloan Kettering Cancer Center §Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00000478-201603000-000
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000556DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970426PMC
March 2016

Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy.

Cancer Epidemiol Biomarkers Prev 2015 Jun 23;24(6):913-20. Epub 2015 Mar 23.

Department of Gastroenterology and Nutrition Service, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-1321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452431PMC
June 2015

Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency.

Mod Pathol 2014 Oct 28;27(10):1405-11. Epub 2014 Feb 28.

1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.237DOI Listing
October 2014

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.

J Clin Oncol 2014 Oct 8;32(29):3275-83. Epub 2014 Sep 8.

Mark E. Sherman, Phuong L. Mai, Lori Minasian, and Mark H. Greene, National Cancer Institute, Rockville; Olga B. Ioffe, University of Maryland Medical Center; Brigitte M. Ronnett, Johns Hopkins Medical Institutions, Baltimore; Chad A. Hamilton, Walter Reed National Military Medical Center, Bethesda, MD; Marion Piedmonte, Roswell Park Cancer Institute, Buffalo; Stephanie V. Blank, New York University School of Medicine; Noah D. Kauff, Memorial Sloan Kettering Cancer Center; New York, NY; Linda Van Le, University of North Carolina at Chapel Hill, Chapel Hill, NC; Iouri Ivanov, Columbus Cancer Council, Columbus, OH; Maria C. Bell, Sanford University of South Dakota Medical Center, Sioux Falls, SD; Paul DiSilvestro, Women and Infants Hospital, Providence, RI; Krishnansu S. Tewari, University of California Medical Center Irvine, Orange, CA; Katie Wakeley, Tufts University; Steven J. Skates, Massachusetts General Hospital, Boston, MA; S. Diane Yamada, University of Chicago, Chicago; Gustavo Rodriguez, North Shore University Health System, Evanston, IL; David S. Alberts, University of Arizona Cancer Center, Tucson, AZ; Joan L. Walker, University of Oklahoma, Oklahoma City, OK; and Karen Lu, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.1987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178524PMC
October 2014

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

J Clin Oncol 2014 Mar 3;32(8):833-40. Epub 2014 Feb 3.

Karen H. Lu, Molly Daniels, and Cathy Burke, MD Anderson Cancer Center, Houston; Linda Robinson, Simmons Comprehensive Cancer Center, Dallas, TX; Marie E. Wood, University of Vermont, Burlington, VT; James Ford, Stanford University Medical Center, Stanford, CA; Noah D. Kauff, Memorial Sloan-Kettering Cancer Center, New York, NY; Wendy Kohlmann, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Noralane M. Lindor, Mayo Clinic, Scottsdale, AZ; Therese M. Mulvey, Southcoast Centers for Cancer Care, Fall River; Sapna Syngal, Dana-Farber Cancer Institute, Brigham and Women's Hospital; Kevin S. Hughes, Avon Comprehensive Breast Evaluation Center, Massachusetts General Hospital, Boston, MA; Wendy Rubinstein, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD; Elena M. Stoffel, University of Michigan, Ann Arbor, MI; Carrie Snyder, Creighton University, Omaha, NE; and Janette K. Merrill and Dana Swartzberg Wollins, American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.9257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940540PMC
March 2014

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).

Int J Gynecol Cancer 2013 Nov;23(9):1603-11

*Department of Surgery, Gynecology Service, †Department of Pathology, and ‡Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and §Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e3182a80ac8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979072PMC
November 2013

Screening for familial ovarian cancer: a ray of hope and a light to steer by.

J Clin Oncol 2013 Jan 3;31(1):8-10. Epub 2012 Dec 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.4678DOI Listing
January 2013

Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.

Gynecol Oncol 2012 Aug 8;126(2):224-8. Epub 2012 May 8.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 E 66th Street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909698PMC
August 2012

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

Mod Pathol 2012 Apr 23;25(4):625-36. Epub 2011 Dec 23.

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2011.183DOI Listing
April 2012

Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers.

Gynecol Oncol 2011 Nov 19;123(2):196-9. Epub 2011 Aug 19.

Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.07.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677700PMC
November 2011

Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies.

Curr Opin Oncol 2011 Sep;23(5):526-30

aGynecology Service, Department of Surgery bClinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2011/09000/Heredita
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e3283499da9DOI Listing
September 2011

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.

Authors:
Paul D P Pharoah Rachel T Palmieri Susan J Ramus Simon A Gayther Irene L Andrulis Hoda Anton-Culver Natalia Antonenkova Antonis C Antoniou David Goldgar Mary S Beattie Matthias W Beckmann Michael J Birrer Natalia Bogdanova Kelly L Bolton Wendy Brewster Angela Brooks-Wilson Robert Brown Ralf Butzow Trinidad Caldes Maria Adelaide Caligo Ian Campbell Jenny Chang-Claude Y Ann Chen Linda S Cook Fergus J Couch Daniel W Cramer Julie M Cunningham Evelyn Despierre Jennifer A Doherty Thilo Dörk Matthias Dürst Diana M Eccles Arif B Ekici Douglas Easton Peter A Fasching Anna de Fazio David A Fenstermacher James M Flanagan Brooke L Fridley Eitan Friedman Bo Gao Olga Sinilnikova Aleksandra Gentry-Maharaj Andrew K Godwin Ellen L Goode Marc T Goodman Jenny Gross Thomas V O Hansen Paul Harnett Matti Rookus Tuomas Heikkinen Rebecca Hein Claus Høgdall Estrid Høgdall Edwin S Iversen Anna Jakubowska Sharon E Johnatty Beth Y Karlan Noah D Kauff Stanley B Kaye Georgia Chenevix-Trench Linda E Kelemen Lambertus A Kiemeney Susanne Krüger Kjaer Diether Lambrechts James P Lapolla Conxi Lázaro Nhu D Le Arto Leminen Karin Leunen Douglas A Levine Yi Lu Lene Lundvall Stuart Macgregor Tamara Marees Leon F Massuger John R McLaughlin Usha Menon Marco Montagna Kirsten B Moysich Steven A Narod Katherine L Nathanson Lotte Nedergaard Roberta B Ness Heli Nevanlinna Stefan Nickels Ana Osorio Jim Paul Celeste Leigh Pearce Catherine M Phelan Malcolm C Pike Paolo Radice Mary Anne Rossing Joellen M Schildkraut Thomas A Sellers Christian F Singer Honglin Song Daniel O Stram Rebecca Sutphen Annika Lindblom Kathryn L Terry Ya-Yu Tsai Anne M van Altena Ignace Vergote Robert A Vierkant Allison F Vitonis Christine Walsh Shan Wang-Gohrke Barbara Wappenschmidt Anna H Wu Argyrios Ziogas Andrew Berchuck Harvey A Risch

Clin Cancer Res 2011 Jun 8;17(11):3742-50. Epub 2011 Mar 8.

Department of Oncology, University of Cambridge, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/17/11/3742.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-10-3405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107901PMC
June 2011

Genome-wide association studies of cancer predisposition.

Hematol Oncol Clin North Am 2010 Oct;24(5):973-96

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2010.06.009DOI Listing
October 2010

Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.

Breast Cancer Res Treat 2010 Sep 11;123(2):581-5. Epub 2010 Mar 11.

Department of Medicine, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 192, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-010-0818
Web Search
http://link.springer.com/10.1007/s10549-010-0818-y
Publisher Site
http://dx.doi.org/10.1007/s10549-010-0818-yDOI Listing
September 2010

Genome-wide association studies of cancer.

J Clin Oncol 2010 Sep 28;28(27):4255-67. Epub 2010 Jun 28.

Clinical Genetics Service andthe Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, NY, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.7816DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953976PMC
September 2010

Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers.

Gynecol Oncol 2009 Oct 3;115(1):135-137. Epub 2009 Jul 3.

Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756313PMC
October 2009

ATR mutations in endometrial cancer: a window into the role of mismatch repair defects.

Authors:
Noah D Kauff

J Clin Oncol 2009 Jul 26;27(19):3077-8. Epub 2009 May 26.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.22.2125
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.22.2125DOI Listing
July 2009

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

J Natl Cancer Inst 2009 Jan 13;101(2):80-7. Epub 2009 Jan 13.

Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djn442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639318PMC
January 2009

How should women with early-onset endometrial cancer be evaluated for lynch syndrome?

Authors:
Noah D Kauff

J Clin Oncol 2007 Nov 9;25(33):5143-6. Epub 2007 Oct 9.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2007.13.4940
Publisher Site
http://dx.doi.org/10.1200/JCO.2007.13.4940DOI Listing
November 2007

Screening and prevention of hereditary gynecologic cancers.

Semin Oncol 2007 Oct;34(5):406-10

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2007.07.004DOI Listing
October 2007

Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.

J Clin Oncol 2007 Jul;25(20):2921-7

Gynecology Service, Department of Surgery, and Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.3449DOI Listing
July 2007

Does a BRCA mutation plus tamoxifen equal hysterectomy?

Gynecol Oncol 2007 Jan;104(1):3-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.11.015DOI Listing
January 2007

Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.

Cancer Epidemiol Biomarkers Prev 2006 Nov;15(11):2311-3

Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-0176DOI Listing
November 2006

The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy.

Gynecol Oncol 2006 Aug 23;102(2):315-8. Epub 2006 Jan 23.

Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.12.021DOI Listing
August 2006

Reducing the risk of gynecologic cancer in the Lynch syndrome.

N Engl J Med 2006 Jan;354(3):293-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe058284DOI Listing
January 2006

Laparoscopic bilateral salpingo-oophorectomy in breast cancer patients after transverse rectus abdominus myocutaneous flap reconstructive surgery.

Gynecol Oncol 2005 Dec 16;99(3):720-5. Epub 2005 Sep 16.

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082580500674
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2005.07.120DOI Listing
December 2005

Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

J Natl Cancer Inst 2005 Sep;97(18):1382-4

Department of Gynecology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dji281DOI Listing
September 2005

Hereditary ovarian cancer in Ashkenazi Jews.

Fam Cancer 2004 ;3(3-4):259-64

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-004-9552-0DOI Listing
February 2005

BRCA mutations and risk of prostate cancer in Ashkenazi Jews.

Clin Cancer Res 2004 May;10(9):2918-21

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
May 2004

Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer.

J Natl Cancer Inst 2004 Jan;96(1):68-70

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djh006DOI Listing
January 2004

Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.

Gynecol Oncol 2003 Jun;89(3):440-6

Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1278 York Avenue, New York, NY 10021-6094, USA.

View Article

Download full-text PDF

Source
June 2003

Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.

Cancer 2003 Apr;97(7):1601-8

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11225DOI Listing
April 2003

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Clin Cancer Res 2002 Dec;8(12):3776-81

Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
December 2002

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

N Engl J Med 2002 May 20;346(21):1609-15. Epub 2002 May 20.

Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa020119DOI Listing
May 2002